State Of Wyoming Fennec Pharmaceuticals Inc. Transaction History
State Of Wyoming
- $778 Million
- Q2 2025
A detailed history of State Of Wyoming transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, State Of Wyoming holds 488 shares of FENC stock, worth $4,694. This represents 0.0% of its overall portfolio holdings.
Number of Shares
488
Previous 1,314
62.86%
Holding current value
$4,694
Previous $8,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding FENC
# of Institutions
80Shares Held
14MCall Options Held
10KPut Options Held
83.8K-
Southpoint Capital Advisors LP New York, NY4.08MShares$39.2 Million0.98% of portfolio
-
Sonic Gp LLC Honolulu, HI2.41MShares$23.2 Million33.54% of portfolio
-
Solas Capital Management, LLC Darien, CT2.23MShares$21.5 Million12.03% of portfolio
-
Black Rock Inc. New York, NY1.19MShares$11.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA967KShares$9.3 Million0.0% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $251M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...